Company / R&D per Share
AYTU BIOPHARMA, INC R&D per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.22
FY2025
5-year range
$0.22 / $2.12
FY2021-FY2025
Trend
-55.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.10 in FY2020 to $5.16 in FY2016.
Based on SEC 10-K filings.
0.22 in FY2025 with a 10-year CAGR of -5.9%.
Declined from $2.12 to $0.22 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -21.6%
- 5-Year CAGR
- +17.7%
- 10-Year CAGR
- -5.9%
Key checks
Key Insights
- In FY2025, r&d per share decreased 55.8% year-over-year.
- Peak r&d per share was recorded in FY2016.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.22 | -55.8% |
| FY2024 | $0.50 | -76.4% |
| FY2023 | $2.12 | +360.9% |
| FY2022 | $0.46 | +3.1% |
| FY2021 | $0.45 | +355.1% |
| FY2020 | $0.10 | -97.6% |
| FY2018 | $4.06 | -20.8% |
| FY2017 | $5.13 | -0.5% |
| FY2016 | $5.16 | +1165.6% |
| FY2015 | $0.41 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026